Analysis of cardiovascular dynamics in pulmonary hypertensive C57BL6/J mice by Shivendra G. Tewari et al.
ORIGINAL RESEARCH ARTICLE
published: 11 December 2013
doi: 10.3389/fphys.2013.00355
Analysis of cardiovascular dynamics in pulmonary
hypertensive C57BL6/J mice
Shivendra G. Tewari1†, Scott M. Bugenhagen1,2, Zhijie Wang3, David A. Schreier3, Brian E. Carlson1,2†,
Naomi C. Chesler3 and Daniel A. Beard1,2*†
1 Biotechnology and Bioengineering Center, Medical College of Wisconsin, Milwaukee, WI, USA
2 Department of Physiology, Medical College of Wisconsin, Milwaukee, WI, USA
3 Department of Biomedical Engineering, University of Wisconsin–Madison, Madison, WI, USA
Edited by:
Zbigniew R. Struzik, The University
of Tokyo, Japan
Reviewed by:
Zhiliang Xu, University of Notre
Dame, USA
Joakim Sundnes, Simula Research
Laboratory, Norway
*Correspondence:
Daniel A. Beard, Department of
Physiology, Medical College of
Wisconsin, 8701 Watertown Plank
Road, Milwaukee, WI 53226, USA
e-mail: beardda@gmail.com
†Present address:
Department of Molecular &
Integrative Physiology, University of
Michigan, Ann Arbor, MI, USA
A computer model was used to analyze data on cardiac and vascular mechanics from
C57BL6/J mice exposed to 0 (n = 4), 14 (n = 6), 21 (n = 8) and 28 (n = 7) days of
chronic hypoxia and treatment with the VEGF receptor inhibitor SUGEN (HySu) to induce
pulmonary hypertension. Data on right ventricular pressure and volume, and systemic
arterial pressure obtained before, during, and after inferior vena cava occlusion were
analyzed using a mathematical model of realistic ventricular mechanics coupled with a
simple model of the pulmonary and systemic vascular systems. The model invokes a
total of 26 adjustable parameters, which were estimated based on least-squares fitting of
the data. Of the 26 adjustable parameters, 14 were set to globally constant values for the
entire data set. It was necessary to adjust the remaining 12 parameters to match data from
all experimental groups. Of these 12 individually adjusted parameters, three parameters
representing pulmonary vascular resistance, pulmonary arterial elastance, and pulmonary
arterial narrowing were found to significantly change in HySu-induced remodeling. Model
analysis shows a monotonic change in these parameters as disease progressed, with
approximately 130% increase in pulmonary resistance, 70% decrease in unstressed
pulmonary arterial volume, and 110% increase in pulmonary arterial elastance in the
28-day group compared to the control group. These changes are consistent with prior
experimental measurements. Furthermore, the 28-day data could be explained only after
increasing the passive elastance of the right free wall compared to the value used for the
other data sets, which is likely a consequence of the increased RV collagen accumulation
found experimentally. These findings may indicate a compensatory remodeling followed
by pathological remodeling of the right ventricle in HySu-induced pulmonary hypertension.
Keywords: pulmonary hypertension, cardiac mechanics, myofiber, stress, strain, re-modeling
INTRODUCTION
Pulmonary arterial hypertension (PAH) is a pathophysiologi-
cal condition of sustained mean pulmonary arterial pressure
greater than 25mmHg at rest with a pulmonary capillary wedge
pressure lower than 15mmHg (Stenmark et al., 2009). It is a
syndrome in which obstruction of pulmonary arteries increases
pulmonary vascular resistance (PVR) leading to right ventricu-
lar (RV) hypertrophy, failure and death (Lumens et al., 2009a;
Ciuclan et al., 2011). The historical median survival for untreated
idiopathic PAH (IPAH) patient is 2.8 years (Gibbs, 2007). The
etiology of PAH is not completely understood, with multiple fac-
tors involved in its pathogenesis (Stenmark et al., 2009; Ciuclan
et al., 2011), the revelation of which is key to designing thera-
peutic strategies. Ciuclan et al. (2011) reported a novel murine
model of PAH that is relevant to pathogenesis of human PAH
and presents incipient right heart failure after 21 days of chronic
hypoxia exposure with SUGEN treatment (HySu). However, they
did not study the mechanical load response of RV compre-
hensively at the whole organ or sarcomere levels. Therefore,
the effect of PAH progression on RV failure remains poorly
understood.
A recent study byWang et al. (2013)measured in vivo hemody-
namics to characterize RVmechanics and cardiovascular function
in mice exposed to HySu for 0, 14, 21, and 28 days. Progressive
changes in RV function were found, suggesting a shift of RV
remodeling from adaptation to maladaptive. However, the in vivo
measurement was at the whole organ level and thus the mechani-
cal load response of RV sarcomere was unclear. Moreover, remod-
eling in the pulmonary vascular bed such as arterial narrowing
and stiffening cannot be directly measured from the RV pressure-
volume relationships. To address these issues, a computer model
of the heart and circulation is used to provide a quantitative
description of the hemodynamic data of Wang et al. (2013).
The computer model simulates realistic ventricular interac-
tions using the TriSeg model (Lumens et al., 2009b) while the
circulation is simulated using a simple lumped parameter model
adapted from Smith et al. (2004). It invokes a total of 26 adjustable
parameters that are estimated based on least-squares fit to the
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measured data. Of these 26 parameters, it was necessary to adjust
12 parameters to match data for each individual animal from
all experimental groups, while 14 were set to globally constant
values for each individual animal from all experimental groups.
Among these 12 individually adjusted parameters, three parame-
ters representing pulmonary vascular resistance, pulmonary arte-
rial elastance, and pulmonary arterial narrowing were found to
significantly change in the diseased experimental groups. In addi-
tion, for the 28-day group it was necessary to adjust the passive
stress-strain curve of right free wall (RW) from the baseline
value used by Lumens et al. (2009b). Specifically, the transition
point of this stress-strain relationship is modified which increases
the slope of the stress-strain curve for the 28-day group, which
may reflect increased collagen accumulation. Mechanical load
response of the RW was calculated as area of the stress-strain
curve, defined as the stroke work density per unit tissue vol-
ume. The model suggests a trend of compensatory increase in
stroke work density for 14- and 21-day groups followed by patho-
logical reduction for 28-day group. Together, these changes in
RW work density potentially indicate the onset of RV dysfunc-
tion. However, the predicted trends in RW work density are not
statistically significant for the number of animals studied.
MATERIALS AND METHODS
EXPERIMENTAL DATA
RV pressure, volume and systemic/aortic pressure data from
Wang et al. (2013) are used to identify the mathematical frame-
work, which simulates the effect of HySu on the cardiovascular
system. Admittance based catheters were used to measure pres-
sure and volume from C57BL6/J mice exposed to HySu for 14,
21, and 28 days to induce PAH. A normoxia control group was
used by vehicle treatment for 21 days in room air conditions.
After initial measurements of pressure and volume, the inferior
vena cava (IVC) was occluded to alter the preload. The vena
cava occlusion (VCO) was limited to a few seconds to min-
imize any response of the baroreflex. (Additionally, urethane
anesthetic used in the experiments effectively suppressed the
baroreflex response). Measurements of hematocrit, RW, left ven-
tricular free wall (LW) plus septal tissue mass were obtained after
euthanasia. For detailed experimental procedures, see Wang et al.
(2013).
COMPUTATIONAL MODEL
The TriSeg model (Lumens et al., 2009b) is used to describe the
ventricular mechanics of the heart and is coupled with a simple
model of the circulation (Smith et al., 2004). The TriSeg model,
described in detail by Lumens et al. (2009b), represents the heart
as three thick-walled spherical segments which meet at a junc-
tion margin encapsulating the left ventricle (LV) and RV cavity. It
incorporates mechanical interactions between LW, RW and sep-
tum resulting in realistic LV and RV pump mechanics. The wall
geometries are used to calculate representative myofiber strain for
each wall, which is used to calculate myofiber stress using consti-
tutive equations describing sarcomere mechanics. Myofiber stress
and wall geometries, in turn, are used to calculate representa-
tive radial and axial tensile forces acting on the junction line.
The septal geometry is adjusted so that equilibrium of tensile
forces at the junction is maintained. For simulating the mouse
heart, the TriSeg model was modified to account for physio-
logical heart-rate changes by adapting mechanical activation of
sarcomere on a beat-to-beat basis. The mechanical activation of
sarcomeres in the TriSeg Model (Lumens et al., 2009b), which
is physiologically related to intracellular calcium concentration,
is governed by the three time-constants controlling calcium rise
and decay times, and sarcomere contraction duration (see sec-
tion 1 of the supplementary material). These time-constants were
scaled by heart-rate accounting for physiological changes in sar-
comere dynamics for each cardiac cycle (see section 1 of the
supplementary material for details).
The lumped parameter model used to represent the circula-
tion is shown in Figure 1. In order to simulate an occlusion of the
IVC, the systemic circulation is split into two parallel pathways,
one representing the anterior body circulation that drains into the
vena cava (VC), one representing the posterior body circulation
draining first into the IVC and then into VC. The IVC compart-
ment was added to capture the RV volume overshoot seen in
the experiments. The pulmonary circulation is made up of two
elastic compartments representing pulmonary arteries (PA) and
pulmonary veins (PU). The resistances, labeled R, simulate the
resistance experienced by blood passing through arteries/veins.
The diodes represent the one-way valves at the inlet and exit of
the ventricles; the valves also have resistance associated with them.
The flow between compartments does not account for inertia and
is calculated (Smith et al., 2004):
Q = P1 − P2
R
, (1)
where the flow rate (Q) from compartment 1 to 2 is calculated
from pressure in compartment 1 (P1) and compartment 2 (P2)
and the resistance between the two compartments (R). The rate
at which volume of a compartment changes is given by:
dV
dt
= Qin − Qout. (2)
Assuming a linear relationship between pressure and volume,
pressure in a compartment is calculated as:
Px = (Vx − Vdx)Cx, (3)
where Cx is the compliance and Vdx represents an unstressed vol-
ume of compartment x. Subscripts on pressure, elastance, and
volume variables and parameters specify the model compartment
with which each elastance, pressure, and volume is associated.
These subscripts are defined in the legend of Figure 1.
The VCO perturbation is captured in the model by increasing
the resistance RPBC,D during the occlusion period by an amount
determined by the adjustable parameter pVCO which represents
the percentage of occlusion. Specifically, during the period of
occlusion the resistance RPBC,D is increased by a factor 1/(1-
pVCO). When the occlusion is released, the resistance is returned
to the non-occlusion value.
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FIGURE 1 | Lumped parameter model of the circulation. R represents
resistance experienced by blood flowing through arteries/veins or valves. C
represents compliance of an elastic chamber. P represents pressure in an
elastic chamber. (A) Model of the systemic circulation (AV, aortic valve; AO,
aorta; ABC, anterior-body circulation which drains into the superior vena cava;
PBC, posterior body circulation which drains into inferior vena cava; IVC,
inferior vena cava upstream of occlusion; VC, vena cava; TC, tricuspid valve).
The compliance CVC represents the compliance of the superior vena cava and
the compliance of the inferior vena cava that is downstream of the site of
occlusion. (B) Blood flow through the pulmonary vascular bed (PV, pulmonic
valve; PA, pulmonary artery; PVB, pulmonary vascular bed; PU, pulmonary
vein; MT, mitral valve).
PARAMETER ESTIMATION
The set of parameter values, δ, representing the control (0-day)
group, is obtained using simultaneous least squares fitting of the
pressure and volume recordings of all data from this group:
min
δ
E(δ), E(δ) =
∑
∀X
(Xdata − Xmodel(δ))
max(X) − min(X)
2
. (4)
Here X represents the variables RV pressure, RV volume, and
aortic pressure. The minimization of the mean residual error
(objection function) E(δ) for optimal estimation of the model
parameter set is carried out using MATLAB (The MathWorks,
Natick, MA) based code of FORTRAN package called PIKAIA
implementing Genetic Algorithm (Charbonneau, 2002).
The control group values of all parameters, listed in Table 1,
were estimated for each individual animal. From this analysis (see
results and Table 1), 14 of the model parameters (indicated in
Table 1) varied less than 5% within the group. It was therefore
possible to set the values of these 14 parameters to themean values
from the control group and obtain reasonable fits to the experi-
mental data for individuals from all groups. This set of parameters
is denoted “globally fixed” in Table 1. The remaining 12 param-
eters, indicated “individually estimated” are estimated for each
individual from each group.
The individually estimated set of parameters (ALWm, ref, A
SW
m, ref,
ARWm, ref, vmax, RPVB, EPA, VdPA, RABC, RPBC, EVC, VdVC, pVCO)
includes 4 parameters associated with the heart model and 8 asso-
ciated with the circulatory model. Three members of this set are
associated with the pulmonary circulation: RPVB, EPA, VdPA.
A significant increase in hematocrit levels is observed in the
mice subjected to HySu compared to control (Wang et al., 2013).
The observed increase in hematocrit from 48 ± 1 in the control
group to ∼70 in the PAH groups is expected to be associated with
a substantial increase in blood viscosity. Associated effects on the
effective resistances in the circulation are accounted for in the
estimated resistance values.
For all parameters, two-tailed student’s t-test was performed to
compare the differences between the control group and the dis-
eased group (14, 21, and 28-day). All results are represented as
mean ± standard deviation (shown in Tables 1, 2). A p < 0.05
is considered as statistically significant. A list of all the parameters
for the four groups can be found in section 3 of the supplementary
material.
RESULTS
NORMOXIA SIMULATIONS
The control parameter (or baseline parameter) set is estimated
from 4 independent control mouse recordings of RV pressure,
volume, and aortic pressure. Heart rate is calculated from the aor-
tic pressure time series to drive the sarcomere mechanics model
(see section 1 of the supplementary material for details), which
in turn modifies excitation-contraction of heart on a beat-to-beat
basis.
Figure 2 shows a representative data set from the control
group. The RV pressure and volume decreases with VCO.
Following the release of the occlusion there is an overshoot in RV
volume (Figure 2B) that is effectively captured by the model. In
themodel this phenomenon follows from interaction between the
IVC compliance upstream to the point of occlusion; see Figure 1)
and VC compliance (downstream to the point of occlusion; see
Figure 1). During the occlusion, the vasculature upstream of the
occlusion increases in volume and the release of the accumulated
fluid drives the overshoot in RV filling. The degree of overshoot
is due to interaction between the vena cava compliances upstream
(CIVC) and downstream (CVC) of the point of occlusion (RPBC,D).
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Table 1 | Estimated parameters for 0-day hypoxic mice (n = 4).
Parameter Description Value Unit
TriSeg PARAMETERS
ALWm, ref* Reference mid-wall surface area of LW 0.59±0.07 cm2
ASWm, ref* Reference mid-wall surface area of SW 0.10±0.01 cm2
ARWm, ref* Reference mid-wall surface area of RW 0.50±0.01 cm2
vmax* Sarcomere contractile velocity with no load 12.36±0.8 μm/s
τ‡D Factor scaling contraction decay time 53.6±2.9 ms
τ‡R Factor scaling contraction rise time 76.6±2.4 ms
τ‡SC Factor scaling duration of contraction 437.1±10.9 ms
CIRCULATORY PARAMETERS
R‡MT Mitral-valve resistance 3.56±0.02 mmHg·s/mL
R‡AV Aortic-valve resistance 0.013±0.0001 mmHg·s/mL
R‡TC Tricuspid-valve resistance 0.019±0.0001 mmHg·s/mL
R‡PV Pulmonic-valve resistance 12.024±0.12 mmHg·s/mL
RPVB* Pulmonary vascular bed resistance 154.32±11.1 mmHg·s/mL
RABC* Anterior body circulation resistance 1442.6±86.2 mmHg·s/mL
R†PBC* Posterior body circulation resistance 569.6±32.9 mmHg·s/mL
VdVC* Unstressed vena cava volume 0.45±0.04 mL
Vd‡IVC Unstressed IVC volume 1.04±0.05 mL
VdPA* Unstressed pulmonary artery volume 0.16±0.01 mL
Vd
PU‡
Unstressed pulmonary vein volume 0.42±0.03 mL
Vd
AO‡
Unstressed aorta volume 0.027±0.001 mL
EVC* Vena-cava elastance 103.8±6.6 mmHg/mL
E
IVC‡
IVC elastance 80.02±4.3 mmHg/mL
EPA* Pulmonary artery elastance 437.78±26.6 mmHg/mL
E
PU‡
Pulmonary vein elastance 188.5±10.2 mmHg/mL
E
AO‡
Aorta elastance 3634.3±91.7 mmHg/mL
PREDICTED IVC FLOW AND ESTIMATED VCO%
IVC Flow IVC flow percentage 71.6±0.02 –
pVCO‖* Percentage of IVC occluded 88.6±1.4 –
‡Globally fixed parameters.
*Individually estimated parameters.
†RPBC represents total posterior body circulation resistance. The resistances upstream and downstream to inferior vena cava compliance (CIVC ) are constrained to
have a 90:10 (RPBC,U : RPBC,D) ratio.
‖Represents percent occlusion downstream to inferior vena cava compliance (CIVC ).
Heart rate remains with ±0.7% of the mean value for the time
course illustrated in Figure 2. The lack of an increase in heart
rate during the period of occlusion indicates that the baroreflex
is effectively suppressed by the anesthetic, as baroreflex fibers are
expected to respond to a pressure drop within, as soon as, a single
beat (Coleridge et al., 1984).
Figure 3 shows a detail of the data andmodel simulations from
a representative 14-day mouse, illustrating the steady conditions
before occlusion. Representative comparisons of experimental
data and model simulations for each experimental group individ-
ual are provided in section 2 of the supplementary material.
IVC OCCLUSION AND RELEASE
Figures 4–7 show model simulation and experimental data for a
representative individual from each group during baseline (steady
state), beginning of occlusion and release of occlusion. To effec-
tively illustrate behavior during key periods of the experimental
protocol, these figures illustrate one second duration of base-
line (before VCO), the first second following occlusion (VCO
begin), and one second of data around the occlusion release
(VCO release). In all cases, the model is able to capture the key
circulatory dynamics and the increase in baseline RV pressure
(Figures 4A, 5A, 6A, 7A) and end-diastolic volume (Figures 4B,
5B, 6B, 7B) associated with chronic exposure to HySu.
Following VCO release, the RV pressure and volume return
to their baseline values within a few heart beats for 0, 14, and
21-day hypoxic mice (see Figures 4C,F, 5C,F, 6C,F). However,
for 28-day hypoxic mice, RV pressure (and volume) takes sev-
eral beats to return to the baseline values (see Figures 7C,F). This
phenomenon may be related to an increase in the passive stiffness
of the RV free wall. Indeed, it was found that the model could
not effectively capture the experimental observation for the 28-
day group based on varying only the parameters listed in Table 2.
For this group, it was necessary to adjust the passive myofiber
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Table 2 | Parameters estimated to represent HySu dependent changes in model.
Parameter 0-day (n = 4) 14-day (n = 6) 21-day (n = 8) 28-day (n = 7)
TriSeg PARAMETERS
ALWm, ref 0.59±0.07 0.59±0.09 0.60±0.06 0.61± 0.08
ASWm, ref 0.10±0.01 0.12±0.02 0.11±0.01 0.11± 0.01
ARWm, ref 0.50±0.01 0.57±0.04* 0.59±0.05* 0.60± 0.03*
vmax 12.36±0.8 14.4±4.2 14.1±3.1 15.2± 3.8
CIRCULATORY PARAMETERS
RPVB 154.32±11.1 286.52±57.2* 265.5±43.4* 356.6± 37.6*
EPA 437.78±26.6 560.3±101.7 622.5±172.1 938.6± 161.6*
VdPA 0.16±0.01 0.12±0.028 0.121±0.031 0.048± 0.03*
R†ABC 1442.6±86.2 1946±394.3 1769.2±271.1 1883.3± 453.2
R†PBC 569.6±32.9 804.3±121.9* 644.3±63.5 741± 61.8*
EVC 103.8±6.6 103.8±25.3 123.0±45.5 69.8± 16.2*
VdVC 0.45±0.04 0.40±0.07 0.43±0.03 0.49± 0.05
pVCO 88.6±1.4 81.21±0.07 80.8±0.04* 89.6± 0.03
†These resistances were increased from their baseline values (shown in Table 1) to account for blood hematocrit increase in hypoxic mice.
*Indicates rejection of null-hypothesis at 5% significance level using two-tailed student’s t-test with p < 0.05 vs. 0-day hypoxic mice.
FIGURE 2 | A representative 0-day hypoxic mice data set (thin solid
line) used for determining control parameter estimates. The model
simulations are shown as dashed line. (A–C) RV pressure, RV volume, and
Aortic pressure. (D) Heart-rate in beats per minute used to modify
excitation—contraction of heart on a beat-to-beat basis.
stress-strain curve used in the TriSeg heart model. Figure 8 shows
the passive stress-strain relationship obtained from the default
parameterization of the TriSeg model (solid curve). This parame-
terization was used for all 0, 14, and 21-day simulations. Tomatch
the data for the 28-day group, RV free wall passive stiffness was
increased by lowering the transition point of passive stress gener-
ation, which is captured in the first term of the empirical passive
stress-strain relationship (For details see section 1 of the supple-
mentary material). This predicted increase in passive stiffness is
consistent with the increase in RW collagen accumulation found
by Wang et al. (2013). This proposed explanation of the 28-day
data does not exclude other explanations, such as remodeling of
RV and septal geometry that is not fully captured by our model.
FIGURE 3 | Baseline RV pressure, RV volume, and aortic pressure of a
representative 14-day hypoxic mice shown for 1-s duration. (A) Aortic
pressure recording (thin solid line) and model simulation (thick dashed line).
(B) Heart-rate during the period. (C) RV pressure data (thin solid line; lower
graph) and model (thick dashed line), and RV volume data (thin solid line;
upper graph) and model (thick dashed line).
DISCUSSION
It is known that PAH is associated with structural remodeling
of the pulmonary circulation resulting in increased pulmonary
vascular resistance (Stenmark and McMurtry, 2005; Wang and
Chesler, 2011). Based on model fitting of experimental data
obtained from a mouse model of PAH, pulmonary vascular
resistance (RPVB), pulmonary arterial elastance (EPA), and pul-
monary arterial narrowing (VdPA) were estimated as functions of
PAH progression (see Figure 9). This analysis suggests monotonic
changes in these parameters as PAH progressed, with ∼130%
and ∼110% increases in RPVB and EPA after 28 days of PAH
(Estimated increases in both of these parameters are statistically
significant after 28-days of HySu, p < 0.001). The predicted
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FIGURE 4 | RV pressure (A–C) and RV volume (D–F) data (thin solid line) with model simulations (thick dashed line) shown for a representative 0-day
hypoxic mice.
FIGURE 5 | RV pressure (A–C) and RV volume (D–F) data (thin solid line) with model simulations (thick dashed line) shown for a representative
14-day hypoxic mice.
increase in RPVB is consistent with the experimental measurement
on total PVR by Wang et al. (2013). The changes in EPA sug-
gest a continuous stiffening of the pulmonary vascular bed with
PAH development, which is as expected but cannot be obtained
directly from the in vivo pressure-volume loops. It is known that
pulmonary vascular resistance and pulmonary arterial elastance
are major contributors to the increased RV afterload, and con-
sequently RV failure (Naeije and Huez, 2007). To delineate the
individual contributions of RPVB and EPA, we performed model
simulations with either RPVB or EPA or both set to 1.5 times
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FIGURE 6 | RV pressure (A–C) and RV volume (D–F) data (thin solid line) with model simulations (thick dashed line) shown for a representative
21-day hypoxic mice.
FIGURE 7 | RV pressure (A–C) and RV volume (D–F) data (thin solid line) with model simulations (thick dashed line) shown for a representative
28-day hypoxic mice. Please note that the time taken by RV pressure (and volume) to its baseline (panels C and F) is longer than 0, 14, and 21-day individuals.
their control values (see section 4 of the supplementary material).
Model simulations reveal that increased RPVB and EPA individ-
ually contribute more toward increased afterload and preload,
respectively. However, the increases in afterload and preload are
more prominent when RPVB and EPA are increased together (see
section 4 of the supplementary material).
Abe et al. (2010) reported that HySu exposure in rat leads
to progressive pulmonary hypertension and vascular remodel-
ing. Predicted changes in unstressed volumeVdPA and pulmonary
arterial elastance EPA are not statistically significant for the 14-day
group. Similarly, the predicted reduction in VdPA and increase in
EPA for the 21-day group are not statistically significant. However,
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the decrease in VdPA and increase in EPA are statistically sig-
nificant for the 28-day group (p < 0.001), suggesting significant
pulmonary vascular remodeling at this stage in response to HySu.
It has been reported that the increased afterload associated
with chronic hypoxia exposure alone will lead to RV functional
adaptation to maintain ventricular-vascular coupling (Wauthy
et al., 2004). However, a more severe stage of PAH associated
with sustained increase in afterload will lead to the ventricular-
vascular decoupling and RV failure (Lankhaar et al., 2006). The
mechanism for RV changes from adaptation to dysfunction or
failure at different stages of PAH remains largely unknown. In
this modeling study, the failure of the normotensive passive stress-
strain relationship, for the RW, to explain the data from the
28-day group suggests a substantial increase in passive myocar-
dial stiffness after 28-day of HySu and possibly the transition to
dysfunction or failure.
To investigate the effect of HySu on mechanical load response
of RV, the RW stroke work density (defined as contractile
myofiber work per unit tissue volume) was calculated. Stroke
work density is computed as the area enclosed by the myofiber
FIGURE 8 | Modified myofiber stress-strain relationship for the RW
mechanics of a 28-day hypoxic individual (dashed line) as compared to
0, 14, and 21-day individuals (solid line). Zero myofiber strain
corresponds to reference sarcomere length of 2.0μm. Positive strain is
following tensile stress and negative under compressive stress.
stress-natural strain loop (Kroon et al., 2009; Lumens et al.,
2009a):
wf =
∮
σf dεf , (5)
where σf is Cauchy myofiber stress, εf is natural myofiber strain,
and wf is RW stroke work density. Calculated mean stroke work
densities for the four groups are shown in Figure 10. Results indi-
cate an increase in RW stroke work density for the 21-day group
(compared to the control and 14-day groups) that may be indica-
tive of increased contractility in response to increased afterload
(Wauthy et al., 2004). This increase in RW stroke work density is
followed by a decrease in the 28-day group, suggesting a patholog-
ical/maladaptive remodeling in response to sustained increase in
afterload. However, due to a large degree of individual variability,
these trends are not found to be statistically significant.
Wang et al. (2013) report RV stroke work and stroke work
density for 0, 14, 21, and 28-day group individuals suggesting
a monotonic increase in stroke work as a function of days of
HySu exposure but no apparent change in stroke work density
FIGURE 10 | Stroke work density of RW which is the area of the
myofiber stress-strain curve, and is defined as contractile myofiber
work per unit of tissue volume per beat. The closed circles represent
mean (with standard error) taken over 0-day (n = 4), 14-day (n = 6), 21-day
(n = 8), and 28-day (n = 7) hypoxic mice group.
FIGURE 9 | (A) Pulmonary vascular resistance (RPVB), (B) Pulmonary
artery elastance (EPA), and (C) unloaded pulmonary artery volume
(VdPA) as a function of increasing days of hypoxia and treatment
with SUGEN. The closed circles represent mean (with standard
error) taken over 0-day (n = 4), 14-day (n = 6), 21-day (n = 8), and
28-day (n = 7) hypoxic mice group. The decrease in VdPA and
increase in EPA is statistically significant only for the 28-day group
(p < 0.001).
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[See Figure 6 of Wang et al. (2013)]. There are several reasons
why the mean of model predictions of stroke work density do not
follow the same trend as those reported by Wang et al. (2013).
First, the model tends to underestimate the peak diastolic vol-
ume compared to the data for individuals from the 28-day group
(see Figure 7D and Figures S19–S25). Second, calculated stroke
work density in Figure 10 corresponds solely to the contribution
from the RW while work computed from the area of the pressure
volume loop corresponds to the whole ventricle. Thus whether
or not the model-predicted drop in work density for the 28-day
group reflects a transition to RV dysfunction is not clear. Further
analysis of more individuals and/or individuals with more severe
disease phenotype may shed light on this question.
In sum, the major findings to emerge from this study are:
1. Observed increases in pulmonary vascular resistance associ-
ated with PAH are accompanied by commensurate increases
in pulmonary arterial stiffness. Predicted changes in vascu-
lar resistance and elastance with chronic hypoxia and SUGEN
treatment are illustrated in Figure 9, and tabulated in Table 2.
2. Model analysis predicts a significant inward remodeling of the
pulmonary arteries that becomes apparent only in the later
stage of PAH, i.e., 28-day group. Inward remodeling of the
PA is captured by the parameter VdPA, defining the volume
of PA compartment at zero pressure. Thus the model predic-
tion is that the volume of the PA compartment is significantly
reduced in late stage PAH.
3. Model analysis predicts substantial stiffening of RV in the
28-day group, suggesting a degree of maladaptive remodel-
ing in this group. While the fact that it was not necessary
to increase the passive stiffness of the RV compared to the
baseline to represent the 14- and 21-day groups does not nec-
essarily mean changes in the passive mechanical properties of
the myocardium have not occurred in these groups, it does
demonstrate that any changes that did occur become apparent
only in the 28-day group. This substantial increase in passive
stiffness in the 28-day group is associated with a predicted
drop in the mean of RV free wall stroke work density per beat,
as illustrated in Figure 10.
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